Clinical Trials Logo
  1. Home
  2. Healthy Volunteers
  3. NCT02382393
  4. Details
NCT02382393 Clinical Trial

Reliability and Validity of Online Cognitive Assessments

Healthy Volunteers Clinical Trial

Official title:
Reliability and Validity of Online Cognitive Assessments

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02382393
Other study ID # LL002(p)
Secondary ID
Status Completed
Phase N/A
First received March 3, 2015
Last updated November 11, 2015
Start date March 2015
Est. completion date November 2015

Study information
Verified date November 2015
Source Lumos Labs, Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the concurrent validity (correlation coefficient of scores at 1 time point) between the Brain Performance Test (BPT, Lumos Labs, Inc.) and a validated third party computerized assessment.

Description:

Each subject will complete two sessions, each approximately 1 hour in total duration, approximately 2 weeks apart for a total duration of participation of 2 hours over 2 weeks

Recruitment information / eligibility
Status Completed
Enrollment 1152
Est. completion date November 2015
Est. primary completion date November 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- Electronically signed informed consent

- 18 years of age or older

- Native English-Speaker

- Consistent access to a computer with stable internet connection

Exclusion Criteria:

- Under 18 years of age

- Native language other than English

- Visual impairment that impedes computer use

- Has taken a cognitive assessment or done cognitive training in the past year

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator)

Related Conditions & MeSH terms

Intervention

Other:
• Brain Performance Test (BPT, Lumos Labs, Inc)
A brief, repeatable, online battery of cognitive assessments used to measure functioning in five cognitive domains across time.
• Computerized Assessment
a validated, computerized cognitive assessment tool

Locations
Country Name City State
United States Lumos Labs, Inc. San Francisco California

Sponsors (1)
Lead Sponsor Collaborator
Lumos Labs, Inc.

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary BPT Grand Index Score at Time 1 Baseline No
Primary Computerized Assessment Index at Time 1 Baseline No
Primary Selected raw and scaled BPT and Computerized Assessment matched subtest scores at Time 1 Baseline No
Secondary BPT Grand Index at Time 1 and Time 2 Baseline to 2 weeks No
Secondary Computerized Assessment Index at Time 1 and Time 2 Baseline to 2 weeks No
Secondary Raw and scaled BPT subtest scores at Time 1 and Time 2 Baseline to 2 weeks No
See also
  Status Clinical Trial Phase
Completed NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability Phase 1
Completed NCT05001152 - Taste Assessment of Ozanimod Phase 1
Completed NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Phase 1
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin Phase 1
Completed NCT05050318 - Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Phase 4
Completed NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects Phase 1
Completed NCT00746733 - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Phase 1
Recruiting NCT05929651 - Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy Phase 4
Completed NCT05954039 - Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect N/A
Completed NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants Phase 1
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT05533801 - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Phase 1
Not yet recruiting NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) Phase 2
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT06027437 - A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Phase 1
Recruiting NCT05619874 - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity N/A
Completed NCT05553418 - Investigational On-body Injector Clinical Study N/A
Completed NCT04092712 - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Phase 1

External Links